AU2003273035A1 - Gene vaccine - Google Patents

Gene vaccine

Info

Publication number
AU2003273035A1
AU2003273035A1 AU2003273035A AU2003273035A AU2003273035A1 AU 2003273035 A1 AU2003273035 A1 AU 2003273035A1 AU 2003273035 A AU2003273035 A AU 2003273035A AU 2003273035 A AU2003273035 A AU 2003273035A AU 2003273035 A1 AU2003273035 A1 AU 2003273035A1
Authority
AU
Australia
Prior art keywords
gene vaccine
vaccine
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003273035A
Other languages
English (en)
Inventor
Masutaka Furue
Kunihiro Himeno
Yoshihiko Maehara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyushu TLO Co Ltd
Original Assignee
Kyushu TLO Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyushu TLO Co Ltd filed Critical Kyushu TLO Co Ltd
Publication of AU2003273035A1 publication Critical patent/AU2003273035A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003273035A 2002-10-17 2003-10-16 Gene vaccine Abandoned AU2003273035A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002302816A JP2006096663A (ja) 2002-10-17 2002-10-17 癌遺伝子ワクチン
JP2002-302816 2002-10-17
PCT/JP2003/013279 WO2004035085A1 (fr) 2002-10-17 2003-10-16 Vaccin genique

Publications (1)

Publication Number Publication Date
AU2003273035A1 true AU2003273035A1 (en) 2004-05-04

Family

ID=32105054

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003273035A Abandoned AU2003273035A1 (en) 2002-10-17 2003-10-16 Gene vaccine

Country Status (3)

Country Link
JP (1) JP2006096663A (fr)
AU (1) AU2003273035A1 (fr)
WO (1) WO2004035085A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2697896C (fr) 2007-09-18 2016-06-28 Green Peptide Co., Ltd. Composition inductrice de lymphocytes t cytotoxiques
US9139863B2 (en) 2012-03-16 2015-09-22 Genentech, Inc. Engineered conformationally-stabilized proteins
WO2013137920A1 (fr) * 2012-03-16 2013-09-19 Genentech, Inc. Protéines synthétiques stabilisées du point de vue conformationnel
WO2023068328A1 (fr) * 2021-10-20 2023-04-27 国立大学法人東京大学 Agent inducteur de dégradation de peptide cible
CN113842399B (zh) * 2021-10-28 2024-05-14 闽江学院 一种具有抗肿瘤活性的海洋原生动物游仆虫提取物浸膏
WO2024063788A1 (fr) * 2022-09-23 2024-03-28 BioNTech SE Compositions pour l'administration d'antigènes du paludisme et méthodes associées

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4431401A1 (de) * 1994-08-24 1996-02-29 Max Delbrueck Centrum Lebendvakzine gegen Tumorerkrankungen

Also Published As

Publication number Publication date
JP2006096663A (ja) 2006-04-13
WO2004035085A1 (fr) 2004-04-29

Similar Documents

Publication Publication Date Title
AU2003218483A1 (en) Novel expressed genes
AU2002313559A1 (en) Genes
AU2003301850A1 (en) Hiv vaccine
AU2003285320A1 (en) Vaccine
AU2003289603A1 (en) Tumor vaccine
AU2003228708A1 (en) Elongated member lifting system
AU2003228139A1 (en) Bioreactor
AU2003273035A1 (en) Gene vaccine
AU2003237701A1 (en) Vaccines
AU2003224265A1 (en) Nucleic acid immunization
AU2003294705A1 (en) NtSM GENE
AUPS084502A0 (en) Anti-protozoal vaccine
AU2003208685A1 (en) Podologic aid
AU2003243360A1 (en) Polyamine-mediated transfection
AU2002347346A1 (en) Dna vaccine
AU2003229503A1 (en) Genetic vaccine against rna-viral infections
AU2003277902A1 (en) Acc gene
AU2003241762A1 (en) Dna shuflling
AU2002331950A1 (en) Vaccine
AU2003267384A1 (en) Bhyd gene
AUPS086102A0 (en) Vaccine iii
AU2002328863A1 (en) Oncosuppressive gene
AU2003241946A1 (en) Novel acylase gene
AU2003252991A1 (en) INTERFERON-Alpha INDUCED GENE
AU2003220853A1 (en) Abc transporter-associated gene abcc13

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase